10 trials reported significant improvement in urinary albumin excretion rate after treatment of CHM compared with ACEI/ARB (MD −13.41 μg/min, [−20.63, −6.19]), with significant heterogeneity between the studies (Chi2 = 81.21, I2 = 89%) (Figure 3). The gene discussed is ALB; the disease is choroideremia.